Publications
2025
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry.
Mantovani, M., Bucci, T., Imberti, J. F., Lam, S. H. M., Kotalczyk, A., Boriani, G., . . . Lip, G. Y. H. (2025). Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry.. European heart journal. Quality of care & clinical outcomes, qcaf014. doi:10.1093/ehjqcco/qcaf014
Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II/III.
Liu, Y., Chen, Y., Olier, I., Ortega-Martorell, S., Huang, B., Ishiguchi, H., . . . GLORIA‐AF Investigators. (n.d.). Residual risk prediction in anticoagulated patients with atrial fibrillation using machine learning: A report from the GLORIA-AF registry phase II/III.. European Journal of Clinical Investigation. doi:10.1111/eci.14371
The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry.
Huang, B., Liu, Y., Lam, H. M., Ishiguchi, H., Chao, T. -F., Huisman, M. V., . . . GLORIA‐AF Investigators. (2025). The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post-hoc analysis of GLORIA-AF registry.. European journal of clinical investigation, 55(3), e14378. doi:10.1111/eci.14378
Impact of amyloidosis on outcomes after transcatheter aortic valve implantation.
Gerra, L., Bucci, T., Lam, H. M., Mantovani, M., Argyris, A. A., Alobaida, M., . . . Lip, G. Y. H. (2025). Impact of amyloidosis on outcomes after transcatheter aortic valve implantation.. Revista espanola de cardiologia (English ed.), S1885-5857(25)00045-3. doi:10.1016/j.rec.2025.01.012
Long-term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the GLORIA-AF registry.
Li, M., Huang, B., Lam, S. H. M., Ishiguchi, H., Liu, Y., Olshansky, B., . . . Lip, G. Y. H. (2024). Long-term risks and benefits of oral anticoagulation in atrial fibrillation patients with cancer: A report from the GLORIA-AF registry.. European journal of clinical investigation, e14347. doi:10.1111/eci.14347
Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry.
Lam, S. H. M., Romiti, G. F., Corica, B., Bucci, T., Olshansky, B., Chao, T. -F., . . . GLORIA‐AF Investigators. (2025). Number of Previous Strokes and the Association With Clinical Outcomes of Patients With Atrial Fibrillation: Longitudinal Data From the GLORIA-AF Registry.. Journal of the American Heart Association, e038448. doi:10.1161/jaha.124.038448
Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasis.
Guo, R., Wat, D., Lam, S. H. M., Bucci, T., Tsang, C. T. -W., Cai, A. -P., . . . Yiu, K. -H. (2025). Cardiovascular benefits and safety profile of macrolide maintenance therapy in patients with bronchiectasis.. The European respiratory journal, 65(3), 2401574. doi:10.1183/13993003.01574-2024
2024
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.
Liu, Y., Chen, Y., Lam, S. H. M., Huang, B., Romiti, G. F., Alam, U., . . . GLORIA‐AF Investigators. (2024). Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA-AF registry phase III.. Diabetes, obesity & metabolism, 26(12), 5795-5804. doi:10.1111/dom.15950
Risk of death and thrombosis in patients admitted to the emergency department with supraventricular tachycardias.
Bucci, T., Gerra, L., Lam, S. H. M., Argyris, A. A., Boriani, G., Proietti, R., . . . Lip, G. Y. H. (2024). Risk of death and thrombosis in patients admitted to the emergency department with supraventricular tachycardias.. Heart rhythm, S1547-5271(24)03628-2. doi:10.1016/j.hrthm.2024.11.044
Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry
Huang, B. I., Li, M., Liu, Y., Lam, H. M., Ishiguchi, H., Chao, T. F., . . . Lip, G. (2024). Incidence, characteristics, and prognostic impact of cancers in patients with atrial fibrillation: a report from the GLORIA-AF registry. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.3154
Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population
Ishiguchi, H., Abdul-Rahim, A. H., Huang, B., Lam, H. M., Liu, Y., Olshansky, B., . . . Lip, G. Y. H. (2024). Stratification of residual thromboembolic risk among anticoagulated atrial fibrillation patients: a hierarchical cluster analysis from a global, real-world population. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.480
Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry
Huang, B., Lam, H. M., Ishiguchi, H., Liu, Y., Chao, T. F., Olshansky, B., . . . Lip, G. (2024). Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry. European Heart Journal, 45(Supplement_1). doi:10.1093/eurheartj/ehae666.3319
Worldwide Stroke Burden Due to Low Physical Activity and High Body Mass in Older People: Insights From the Global Burden of Disease 2019
Worldwide Stroke Burden Due to Low Physical Activity and High Body Mass in Older People: Insights From the Global Burden of Disease 2019 (2024). doi:10.1161/blog.20241028.912793
Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.
Ishiguchi, H., Abdul-Rahim, A. H., Huang, B., Lam, S. H. M., Liu, Y., Olshansky, B., . . . GLORIA-AF Investigators. (2024). Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.. Journal of general internal medicine. doi:10.1007/s11606-024-09045-6
Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.
Janota, O., Mantovani, M., Kwiendacz, H., Irlik, K., Bucci, T., Lam, S. H. M., . . . Nabrdalik, K. (2024). Metabolically "extremely unhealthy" obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia Diabetes - Heart Project.. Cardiovascular diabetology, 23(1), 326. doi:10.1186/s12933-024-02420-x
Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.
Lam, S. H. M., Romiti, G. F., Olshansky, B., Chao, T. -F., Huisman, M. V., & Lip, G. Y. H. (2024). Combination therapy of beta-blockers and digoxin is associated with increased risk of major adverse cardiovascular events and all-cause mortality in patients with atrial fibrillation: a report from the GLORIA-AF registry.. Internal and emergency medicine. doi:10.1007/s11739-024-03629-0
Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study.
Shi, L. -H., Lam, S. H. M., So, H., Meng, H., & Tam, L. -S. (2024). Impact of inflammation and anti-inflammatory therapies on the incidence of major cardiovascular events in patients with ankylosing spondylitis: A population-based study.. Seminars in arthritis and rheumatism, 67, 152477. doi:10.1016/j.semarthrit.2024.152477
Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.
Lam, S. H. M., Alam, U., & Lip, G. Y. H. (2024). Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes.. The American journal of cardiology, 223, 183-185. doi:10.1016/j.amjcard.2024.05.001
Refining the Cardiovascular Health Score in Patients With Type 2 Diabetes: Challenges and Opportunities.
Lam, S. H. M., Alam, U., & Lip, G. Y. H. (2024). Refining the Cardiovascular Health Score in Patients With Type 2 Diabetes: Challenges and Opportunities.. JACC. Asia, 4(6), 465-467. doi:10.1016/j.jacasi.2024.04.004
Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng, H., Lam, S. H., So, H., & Tam, L. -S. (2024). Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.. Seminars in arthritis and rheumatism, 65, 152416. doi:10.1016/j.semarthrit.2024.152416
2023
Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study.
Shi, L. -H., Lam, S. H., So, H., Chan, C. Y., Li, T. K., Szeto, C. -C., & Tam, L. -S. (2023). Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: A longitudinal cohort study.. Clinical and experimental hypertension (New York, N.Y. : 1993), 45(1), 2205056. doi:10.1080/10641963.2023.2205056
Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.
So, H., Lam, T. O., Meng, H., Lam, S. H. M., & Tam, L. -S. (2023). Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.. Annals of the rheumatic diseases, 82(11), 1387-1393. doi:10.1136/ard-2023-224185
Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
Lam, T. O., Cheng, I. T., Lam, S. H., Lam, S. H., Mok, C. C., Ho, C. T., . . . Tam, L. -S. (2023). Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.. Rheumatology (Oxford, England), 62(9), 2998-3005. doi:10.1093/rheumatology/kead039
2022
High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.
Shi, L. -H., Lam, S. H., So, H., Li, E. K., Li, T. K., Szeto, C. -C., & Tam, L. -S. (2022). High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study.. Therapeutic advances in musculoskeletal disease, 14, 1759720X221122401. doi:10.1177/1759720x221122401
2021
The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
Wu, D., Wong, P., Lam, S. H. M., Li, E. K., Qin, L., Tam, L. -S., & Gu, J. (2021). The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.. Rheumatology (Oxford, England), 60(4), 1963-1973. doi:10.1093/rheumatology/keaa629
Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.
Lam, S. H., So, H., So, H., Cheng, I. T., Li, E. K., Wong, P., . . . Tam, L. -S. (2021). Association of C-reactive protein and non-steroidal anti-inflammatory drugs with cardiovascular events in patients with psoriatic arthritis: a time-dependent Cox regression analysis.. Therapeutic advances in musculoskeletal disease, 13, 1759720X211027712. doi:10.1177/1759720x211027712
2020
DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.
Lam, S. H. M., Cheng, I. T., Li, E. K., Wong, P., Lee, J., Yip, R. M. -L., . . . Tam, L. -S. (2020). DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study.. Annals of the rheumatic diseases, 79(10), 1320-1326. doi:10.1136/annrheumdis-2020-217595
2019
Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.
Wu, D., Griffith, J. F., Lam, S. H. M., Wong, P. C. H., Shi, L., Li, E. K., . . . Tam, L. -S. (2019). Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.. Arthritis research & therapy, 21(1), 265. doi:10.1186/s13075-019-2043-3
2018
Dr. Tam, <i>et al,</i> reply.
Lam, S. H. -M., Shen, J., & Tam, L. -S. (2018). Dr. Tam, <i>et al,</i> reply.. The Journal of rheumatology, 45(9), 1330-1332. doi:10.3899/jrheum.180439
Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.
Shen, J., Lam, S. H., Shang, Q., Wong, C. -K., Li, E. K., Wong, P., . . . Tam, L. -S. (2018). Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis.. The Journal of rheumatology, 45(2), 218-226. doi:10.3899/jrheum.170025